Joyce Hoek, MSc

Keyphrases

1. Medicine Evaluation 100%
2. Evaluation Board 83%
3. Dutch 66%
4. Journal Guidelines 50%
5. Antibody Verification 50%
6. Reporting Guidelines 50%
7. Antibody Identification 50%
8. Identification Information 50%
9. COVID-19 50%
10. Clinical Trials 50%
11. Remdesivir 50%
12. Biomedical Resources 50%
13. Drug Effects 50%
14. Thought Processes 50%
15. Medicines Regulation 50%
16. Good Decision 50%
17. Primary Antibody 33%
18. Frequentist 25%
19. Clinical Improvement 25%
20. Regulatory Bodies 25%
21. Take-all 25%
22. Bayesian Hypothesis Testing 25%
23. Journal Reporting 25%
24. Community Monitoring 25%
25. Clinical Efficacy 25%
26. Europe 25%
27. Mortality Rate 25%
28. Marketing Approval 25%
29. Efficacy Data 25%
30. Bayesian Approach 25%
31. Investigative Approach 25%
32. Assessment Procedures 25%
33. Effect-based Methods 25%
34. Regulatory Framework 25%
35. Ethnographic Study 25%
36. Uncertainty Evaluation 25%
37. Pharmaceutical Companies 25%
38. Regulatory Experience 25%
39. Biomedical Research 16%
40. Enhanced Awareness 16%
41. Experimental Validation 16%
42. Neuroscience 16%
43. Accurate Reporting 16%
44. Neurology 16%
45. Quasi-experimental Approach 16%
46. Manufacturing Data 16%
47. Replication Crisis 16%
48. Lot-to-lot Variability 16%
49. Small Sample Size 16%
50. Effective Implementation 16%